NCT02468089View on ClinicalTrials.gov

To Compare the Efficacy of Carbepenem Versus Carbepenem Plus GM-CSF in Difficult To Treat Spontaneous Bacterial Peritonitis

NACompletedINTERVENTIONAL

Enrollment

146

Participants

Timeline

Start Date

May 1, 2015

Primary Completion Date

August 31, 2017

Study Completion Date

August 31, 2017

Conditions

Spontaneous Bacterial Peritonitis

Interventions

DRUG

Carbepenem

DRUG

Albumin

DRUG

GMCSF (of Granulocyte-Monocyte Colony-Stimulating Factor) .

Trial Locations (1)

110070

Institute of Liver and Biliary Sciences, New Delhi

All Listed Sponsors

lead

Institute of Liver and Biliary Sciences, India

OTHER

NCT02468089 - To Compare the Efficacy of Carbepenem Versus Carbepenem Plus GM-CSF in Difficult To Treat Spontaneous Bacterial Peritonitis | Biotech Hunter | Biotech Hunter